How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2005-12-31 | 2006-12-31 | 2007-12-31 | 2006-12-31 | 2007-12-31 | |
| Income Statement | ||||||
| Revenue | $28.5B | $33.6B | $38.5B | -- | $10.6B | |
| Gross Profit | $20.3B | $24.4B | $27B | -- | -- | |
| Operating Income | $6.3B | $8.4B | $10.4B | -- | -- | |
| EBITDA | $8.2B | $10.4B | $12.5B | -- | -- | |
| Diluted EPS | $5.53 | $7.21 | $9.30 | -- | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $39B | $36.5B | $39.8B | $44.3B | -- | |
| Total Assets | $101B | $95.1B | $107.7B | $112.7B | -- | |
| Current Liabilities | $42B | $29.4B | $29.6B | $29.9B | -- | |
| Total Liabilities | $70B | $60.5B | $68.1B | $72.6B | -- | |
| Total Equity | $31B | $34.5B | $39.6B | $40B | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-02-06 | 2025-02-06 | 2025-02-06 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
In the current month, RHHVF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RHHVF average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that Roche Holding AG share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about Roche Holding AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Roche Holding AG is a Sell and believe this share price will rise from its current level to --.
The price target for Roche Holding AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Roche Holding AG is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of Roche Holding AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Roche Holding AG shares.
Roche Holding AG was last trading at $457.00 per share. This represents the most recent stock quote for Roche Holding AG. Yesterday, Roche Holding AG closed at $458.53 per share.
In order to purchase Roche Holding AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Operated up to now as a private business, SpaceX will…
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Market Cap: $4.2T
P/E Ratio: 59x
Market Cap: $4.1T
P/E Ratio: 37x
Market Cap: $4T
P/E Ratio: 41x
Silicon Laboratories, Inc. [SLAB] is up 0.91% over the past day.
Enphase Energy, Inc. [ENPH] is down 8.53% over the past day.
Mercury Systems, Inc. [MRCY] is up 2.61% over the past day.